← Back
Data updated: Mar 29, 2026
NANJING KING FRIEND
CardiovascularMetabolic
Generics
NANJING KING FRIEND is a generic drug manufacturer focused on Cardiovascular, Metabolic.
2025
Since
3
Drugs
-
Trials
22
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Metabolic 50%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (3)
Discontinued (0)
Company Info
- First Approval
- 2025-04-02
- Latest
- 2025-12-02
- Applications
- 3